Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.36 is 45% above its 5-year average of -0.66, around the middle of its 5-year range (-3.00–1.71).
79.60% above its 12-month average of -1.77.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.10.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 29 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:16:05.757Z. Historical observations retain their original dates. Historical series through 2024-05-09.
EARNINGS PER SHARE (EPS)
-0.36
EARNINGS PER SHARE (EPS) AVG TTM
-1.77
EARNINGS PER SHARE (EPS) AVG 3Y
-0.44
EARNINGS PER SHARE (EPS) AVG 5Y
-0.66
EARNINGS PER SHARE (EPS) AVG 10Y
-0.10
EARNINGS PER SHARE (EPS) AVG 15Y
0.76
EARNINGS PER SHARE (EPS) AVG 20Y
0.47
CURRENT VS TTM AVG
+79.60%
CURRENT VS 3Y AVG
+18.85%
CURRENT VS 5Y AVG
+45.10%
CURRENT VS 10Y AVG
-269.46%
CURRENT VS 15Y AVG
-147.26%
CURRENT VS 20Y AVG
-176.89%
Viatris Inc.
Market Cap
$19.74B
Earnings Per Share (EPS)
-0.36
TTM Avg
-1.77
3Y Avg
-0.44
5Y Avg
-0.66
Market Cap
$21.00B
Earnings Per Share (EPS)
27.91
TTM Avg
28.29
3Y Avg
23.40
5Y Avg
19.31
Market Cap
$18.45B
Earnings Per Share (EPS)
4.11
TTM Avg
4.00
3Y Avg
3.51
5Y Avg
2.55
Market Cap
$17.09B
Earnings Per Share (EPS)
17.07
TTM Avg
14.35
3Y Avg
11.37
5Y Avg
9.10
Market Cap
$16.00B
Earnings Per Share (EPS)
2.10
TTM Avg
2.25
3Y Avg
2.01
5Y Avg
3.78
Market Cap
$15.38B
Earnings Per Share (EPS)
8.19
TTM Avg
5.85
3Y Avg
6.82
5Y Avg
7.06
Market Cap
$24.13B
Earnings Per Share (EPS)
-7.76
TTM Avg
-4.08
3Y Avg
9.21
5Y Avg
14.48
Market Cap
$14.67B
Earnings Per Share (EPS)
3.19
TTM Avg
2.34
3Y Avg
1.78
5Y Avg
1.33
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $19.74B | -0.36 | -1.77 | -0.44 | -0.66 |
| STERIS plc (STE)vs › | $19.98B | 8.18 | 7.08 | 4.77 | 4.37 |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | 27.91 | 28.29 | 23.40 | 19.31 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.45B | 4.11 | 4.00 | 3.51 | 2.55 |
| Medpace Holdings, Inc. (MEDP)vs › | $17.09B | 17.07 | 14.35 | 11.37 | 9.10 |
| Revvity, Inc. (RVTY)vs › | $16.00B | 2.10 | 2.25 | 2.01 | 3.78 |
| Solventum Corporation (SOLV)vs › | $15.38B | 8.19 | 5.85 | 6.82 | 7.06 |
| BioNTech SE (BNTX)vs › | $24.13B | -7.76 | -4.08 | 9.21 | 14.48 |
| Exelixis, Inc. (EXEL)vs › | $14.67B | 3.19 | 2.34 | 1.78 | 1.33 |
| Incyte Corporation (INCY)vs › | $25.40B | 7.85 | 3.38 | 2.74 | 2.31 |
Trailing EPS (TTM)
$-0.36
Forward EPS (Est.)
$2.50
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.00 |
| 2024-12-31 | -0.53 |
| 2023-12-31 | 0.05 |
| 2022-12-31 | 1.71 |
| 2021-12-31 | -1.05 |
| 2020-12-31 | -1.11 |
| 2019-12-31 | 0.03 |
| 2018-12-30 | 0.69 |
| 2017-12-30 | 1.30 |
| 2016-12-30 | 0.94 |
| 2015-12-30 | 1.80 |
| 2014-12-30 | 2.49 |
| 2013-12-30 | 1.63 |
| 2012-12-31 | 1.54 |
| 2011-12-31 | 1.25 |
| 2010-12-31 | 0.69 |
| 2009-12-31 | 0.31 |
| 2008-12-31 | -0.64 |
| 2007-12-31 | -5.90 |
| 2006-03-31 | 0.80 |
| 2005-03-31 | 0.76 |
| 2004-03-31 | 1.24 |
